Clinical Trial Update: SKB264 Plus QL1706 in Recurrent or Metastatic Cervical Cancer [Phase 2]

View source ↗

Summary

This update describes a Phase 2 clinical trial evaluating the combination of SKB264 and QL1706 for recurrent or metastatic cervical cancer, currently recruiting…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Drugs mentioned

• QL1706
• SKB264

Snippet

Sponsor: Fujian Cancer Hospital | Conditions: Cervical Cancer | Phase 2 | Status: RECRUITING